Welcome!
The Fuh lab is comprised of biologists and gynecologic oncologists working together to advance our understanding of aggressive gynecologic cancers with the aim of improving patient lives.
We focus on identifying pathways involved in metastasis and therapeutic resistance, investigating the influence of the tumor microenvironment, and developing targeted therapeutics with the ultimate goal of fighting gynecologic cancers and improving patient outcomes.
Some of the gynecologic cancer topics we investigate:
- Cancer-associated fibroblasts (CAFs) and their role in the tumor microenvironment
- The role of receptor tyrosine kinases AXL and DDR2
- The role of angiogenesis in metastasis and therapeutic resistance
- Immune response and immunotherapy
- Therapeutic development and clinical trials